Brokerages say Biocon’s move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock pressure likely due to dilution and fundraisingBrokerages say Biocon’s move to fully acquire Biocon Biologics simplifies structure and unlocks value, but near-term stock pressure likely due to dilution and fundraising Latest News [ SOBAN NEWS: International and National ]